olivlawolivlaw

olivLaw · US equity research

Arq, Inc. ARQ

Miscellaneous Chemical Products · SIC 2890 · Vertical: Miscellaneous Chemical Products (SIC 2890)

1.85USD+0.54% · 1 dayClose 04 Nov 2026

Arq is a producer of activated carbon used to purify air, water and soil, with powdered activated carbon (PAC) generating most of its revenue. In 2026 the company reaffirmed its financial guidance but paused granular activated carbon (GAC) production because of design flaws, so the progress of this line is central to its outlook. Quarterly and annual revenue are growing moderately, with figures cited in the dedicated lines.

The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).

At the close of 04 Nov 2026, Arq, Inc. (ARQ) stock was 1.85 USD (+0.54% on the day), with market capitalisation 81.8 m USD, dividend yield 0.00%, beta 1.29, 52-week range 1.64–6.35 USD. Latest reported quarter (Q3 2026): revenue of 38.2 m USD (+8.9% YoY), net income of 2.5 m USD, diluted EPS 0.06 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
81.8 m USD
shares as of 02 Nov 2026
P/E (TTM)
unavailable
Diluted EPS TTM -1.16 · TTM to 30 Sept 2026
E/P (TTM)
-62.92%
TTM to 30 Sept 2026
Dividend yield
0.00%
DPS 12m 0.00
Beta (2y)
1.29
Volatility (1y) 97%
52-week range
1.646.35

Price history

Loading chart…

Technical reading

RSI (14)
47.0
neutral
Bollinger (20, 2)
1.66 – 2.05
in the lower half of the band · %B 0.49 · band width 21.0%
SMA 50 / 200
2.00 / 2.49
downtrend (price < SMA50 < SMA200)
MACD (12, 26, 9)
-0.05 / -0.07
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month−8.4%−1.1%−7.3 pp—
3 months−9.8%−0.5%−9.3 pp—
6 months−19.9%+4.4%−24.3 pp—
Year to date−43.4%+12.3%−55.7 pp—
1 year−71.1%+13.5%−84.7 pp+19.0%
3 years+1.1%+76.4%−75.3 pp−0.5%
5 years−74.0%+63.7%−137.7 pp—
Max drawdown (1y)
−74.2%
05 Nov 2025 → 10 Mar 2026
Max drawdown (5y)
−84.0%
15 Nov 2021 → 20 Jun 2023
Compound annual growth (5y)
−23.6%
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q3 2026 · 30 Sept 2026

Revenue
38.2 m USD
+8.9% YoY
Net income
2.5 m USD
unavailable YoY
Diluted EPS
0.06
unavailable YoY
net / operating
6.5% / 8.2%

Quarterly margins

Quarterly statements · USD

Fiscal yearQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Revenue27.0 m27.2 m28.6 m35.1 m29.4 m29.1 m29.9 m38.2 m
Cost of revenue17.2 m17.3 m19.1 m25.0 m25.4 m19.1 m18.4 m23.0 m
Research & development709.0 k874.0 k2.7 m2.6 m1.2 m982.0 k958.0 k754.0 k
SG&A6.0 m6.1 m5.9 m4.6 m6.0 m7.4 m6.8 m7.2 m
Operating income413.0 k662.0 k-1.8 m-1.1 m-50.5 m-982.0 k-68.0 k3.1 m
Depreciation & amortisation2.5 m2.2 m2.7 m4.0 m2.6 m2.6 m3.5 m4.1 m
Interest expense831.0 k724.0 k594.0 k587.0 k544.0 k705.0 k748.0 k771.0 k
Pre-tax income-1.5 m203.0 k-2.4 m-889.0 k-49.3 m-842.0 k-733.0 k2.5 m
Income tax-194.0 k00012.0 k000
Net income-1.3 m-33.0 k-2.4 m-889.0 k-49.3 m-1.1 m-733.0 k2.5 m
Diluted EPS-0.03 ≈0.00-0.06-0.02-1.18 ≈-0.02-0.020.06
Operating cash flow5.2 m-5.8 m527.0 k ≈5.3 m ≈-2.8 m64.0 k-2.7 m ≈10.3 m ≈
Capex43.0 m3.7 m1.9 m ≈2.2 m ≈783.0 k740.0 k1.2 m ≈780.0 k ≈

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Fiscal years

Fiscal year20182019202020212022202320242025
Revenue23.9 m70.1 m67.4 m100.3 m103.0 m99.2 m109.0 m120.3 m
Revenue YoY−47.2%+192.7%−3.9%+48.9%+2.7%−3.7%+9.9%+10.4%
Net income35.5 m35.5 m-20.3 m60.4 m-8.9 m-12.2 m-5.1 m-52.6 m
Net income YoY+27.2%+0.2%−157.1%unavailable−114.8%unavailableunavailableunavailable
Diluted EPS1.761.93-1.123.27-0.48-0.42-0.14-1.27
Diluted EPS YoY+36.4%+9.7%−158.0%unavailable−114.7%unavailableunavailableunavailable
net %148.1%50.7%-30.1%60.2%-8.7%-12.3%-4.7%-43.7%
Free cash flow-10.4 m54.4 m47.4 m19.8 m-15.0 m-44.2 m-74.7 m-11.3 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
6.6 m USD
Financial debt
28.5 m USD
Net debt
21.9 m USD
Equity
168.4 m USD
Total assets
231.0 m USD
Debt / equity
0.17x
Current ratio
1.04x
ROE
-27.2%
ROA
-20.4%
FCF margin
-9.4%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2023
99.2 m
2024
109.0 m
2025
120.3 m

SEC (XBRL)· 10 Mar 2026verified

Cost of revenue
2023
67.3 m
2024
69.5 m
2025
86.8 m

SEC (XBRL)· 10 Mar 2026verified

Gross profit
2023
31.9 m ≈
2024
39.4 m ≈
2025
33.5 m ≈

SEC (XBRL)· 10 Mar 2026derived

Research & development
2023
3.3 m
2024
4.1 m
2025
7.3 m

SEC (XBRL)· 10 Mar 2026verified

SG&A
2023
34.1 m
2024
28.7 m
2025
22.6 m

SEC (XBRL)· 10 Mar 2026verified

Operating income
2023
-13.3 m
2024
-2.0 m
2025
-53.0 m

SEC (XBRL)· 10 Mar 2026verified

Depreciation & amortisation
2023
10.5 m
2024
8.6 m
2025
11.7 m

SEC (XBRL)· 10 Mar 2026verified

EBITDA
2023
-2.8 m ≈
2024
6.6 m ≈
2025
-41.2 m ≈

SEC (XBRL)· 10 Mar 2026derived

Interest expense
2023
3.0 m
2024
3.3 m
2025
2.4 m

SEC (XBRL)· 10 Mar 2026verified

Pre-tax income
2023
-12.1 m
2024
-5.3 m
2025
-52.6 m

SEC (XBRL)· 10 Mar 2026verified

Income tax
2023
153.0 k
2024
-164.0 k
2025
12.0 k

SEC (XBRL)· 10 Mar 2026verified

Net income
2023
-12.2 m
2024
-5.1 m
2025
-52.6 m

SEC (XBRL)· 10 Mar 2026verified

Diluted EPS
2023
-0.42
2024
-0.14
2025
-1.27

SEC (XBRL)· 10 Mar 2026verified

Weighted average diluted shares
2023
29.1 m
2024
36.1 m
2025
41.5 m

SEC (XBRL)· 10 Mar 2026verified

Dividend per share
2023
—
2024
—
2025
—

SEC (XBRL)· 10 Mar 2021verified

Balance sheet · USD

Cash
2023
45.4 m
2024
13.5 m
2025
6.6 m

SEC (XBRL)· 10 Mar 2026verified

Receivables
2023
16.2 m
2024
14.9 m
2025
15.0 m

SEC (XBRL)· 10 Mar 2026verified

Inventories
2023
19.7 m
2024
19.3 m
2025
15.9 m

SEC (XBRL)· 10 Mar 2026verified

Current assets
2023
86.5 m
2024
52.4 m
2025
43.9 m

SEC (XBRL)· 10 Mar 2026verified

Intangibles (excl. goodwill)
2023
7.9 m
2024
7.6 m
2025
570.0 k

SEC (XBRL)· 10 Mar 2026verified

Total assets
2023
235.5 m
2024
284.4 m
2025
231.0 m

SEC (XBRL)· 10 Aug 2026verified

Accounts payable
2023
14.6 m
2024
21.0 m
2025
15.3 m

SEC (XBRL)· 10 Mar 2026verified

Short-term debt
2023
2.7 m
2024
15.5 m
2025
20.0 m

SEC (XBRL)· 10 Mar 2026verified

Long-term debt
2023
18.3 m
2024
9.4 m
2025
8.5 m

SEC (XBRL)· 10 Mar 2026verified

Current liabilities
2023
23.0 m
2024
44.7 m
2025
42.3 m

SEC (XBRL)· 10 Mar 2026verified

Total liabilities
2023
57.1 m
2024
67.1 m
2025
62.6 m

SEC (XBRL)· 10 Mar 2026verified

Equity
2023
178.4 m †
2024
218.6 m †
2025
168.4 m †

SEC (XBRL)· 10 Aug 2026verified

Cash flow · USD

Operating cash flow
2023
-16.7 m
2024
10.5 m
2025
-2.7 m

SEC (XBRL)· 10 Mar 2026verified

Capex
2023
27.5 m
2024
85.2 m
2025
8.6 m

SEC (XBRL)· 10 Mar 2026verified

Free cash flow
2023
-44.2 m ≈
2024
-74.7 m ≈
2025
-11.3 m ≈

SEC (XBRL)· 10 Mar 2026derived

Investing cash flow
2023
-28.5 m
2024
-85.1 m
2025
-8.2 m

SEC (XBRL)· 10 Mar 2026verified

Financing cash flow
2023
22.9 m
2024
42.7 m
2025
3.7 m

SEC (XBRL)· 10 Mar 2026verified

Dividends paid
2023
0
2024
—
2025
—

SEC (XBRL)· 12 Mar 2024verified

Share repurchases
2023
—
2024
—
2025
—

SEC (XBRL)· 08 Mar 2022verified

Computed indicators

Growth

Revenue growth (YoY)
10.4%
computed by olivLawFY 2025
Revenue CAGR 3Y
5.3%
computed by olivLawFY 2022 → FY 2025
Revenue CAGR 5Y
12.3%
computed by olivLawFY 2020 → FY 2025
EBIT growth (YoY)
unavailable
the base of the ratio is not positive
Net income growth (YoY)
unavailable
the base of the ratio is not positive
Net income CAGR 3Y
unavailable
the base of the ratio is not positive
Net income CAGR 5Y
unavailable
the base of the ratio is not positive
EPS growth (YoY)
unavailable
the base of the ratio is not positive
EPS CAGR 3Y
unavailable
the base of the ratio is not positive
EPS CAGR 5Y
unavailable
the base of the ratio is not positive
FCF growth (YoY)
unavailable
the base of the ratio is not positive

Profitability

Gross margin
32.1%
computed by olivLawTTM to 30 Sept 2026
EBITDA margin
-28.1%
computed by olivLawTTM to 30 Sept 2026
EBIT margin
-38.3%
computed by olivLawTTM to 30 Sept 2026
Net margin
-38.5%
computed by olivLawTTM to 30 Sept 2026
FCF margin
1.1%
computed by olivLawTTM to 30 Sept 2026

Returns

ROE
-25.0%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROA
-19.0%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROIC
-19.0%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROCE
-25.4%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
20.5 m USD
computed by olivLawbalance sheet at 30 Sept 2026
Net debt / EBITDA
unavailable
insufficient data
Debt / equity
0.2x
computed by olivLawbalance sheet at 30 Sept 2026
Interest coverage
-17.5x
computed by olivLawTTM to 30 Sept 2026

Liquidity

Current ratio
1.2x
computed by olivLawbalance sheet at 30 Sept 2026
Quick ratio
0.8x
computed by olivLawbalance sheet at 30 Sept 2026
Cash ratio
0.2x
computed by olivLawbalance sheet at 30 Sept 2026

Cash

Operating cash flow
4.9 m USD
computed by olivLawTTM to 30 Sept 2026
Capital expenditure
3.5 m USD
computed by olivLawTTM to 30 Sept 2026
Free cash flow
1.4 m USD
computed by olivLawTTM to 30 Sept 2026
FCF conversion
unavailable
insufficient data
Cash conversion
unavailable
insufficient data

Efficiency

Days sales outstanding
50 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Days inventory outstanding
70 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Days payables outstanding
59 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Cash conversion cycle
61 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026

Market and valuation

Market capitalisation
81.8 m USD
computed by olivLawbalance sheet at 30 Sept 2026
Enterprise value
102.2 m USD
computed by olivLawbalance sheet at 30 Sept 2026
Market cap / net income TTM
unavailable
insufficient data
P/E (TTM)
unavailable
insufficient data
Earnings yield
-62.9%
computed by olivLawTTM to 30 Sept 2026
P/B
0.5x
computed by olivLawbalance sheet at 30 Sept 2026
P/S
0.6x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
EV/EBITDA
unavailable
insufficient data
EV/EBIT
unavailable
insufficient data
EV/Sales
0.8x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
P/FCF
58.8x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
FCF yield
1.7%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Dividend yield
0.0%
computed by olivLawTTM to 30 Sept 2026
Shareholder yield (distributions)
unavailable
input data missing

Risk

Altman Z
0.79
computed by olivLawbalance sheet at 30 Sept 2026

Valuation

olivLaw classification

Insufficient data
What is missing
  • score weight coverage: 43.8% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

1.85 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 81.8 m USD

Key indicators

Market capitalisation
81.8 m USD
computed by olivLawbalance sheet at 30 Sept 2026
P/E (TTM)
unavailable
insufficient data
P/B
0.5x
computed by olivLawbalance sheet at 30 Sept 2026
EV/EBITDA
unavailable
insufficient data
ROE
-25.0%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Net margin
-38.5%
computed by olivLawTTM to 30 Sept 2026
Revenue growth (YoY)
10.4%
computed by olivLawFY 2025
Dividend yield
0.0%
computed by olivLawTTM to 30 Sept 2026

Coverage and freshness

34/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Sept 2026
Latest balance sheet date: 30 Sept 2026
Share count (cover of the latest filing), as of: 02 Nov 2026
Source: SEC (XBRL)published 04 Nov 2026
verified 2205derived 137

Score by group

44% · Insufficient data

Estimated value range

Low
2.06
USD per share
Mid
2.46
USD per share
High
3.05
USD per share
Price: 1.85 USD
The price is below the range
Potential to the central value: 32.9% (value / price − 1)
Margin of safety: 24.7% (1 − price / value)
Agreement between methods: low · 2 methods used · 2 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 0.83 – 4.42 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)0.83 – 1.69 (Mid 1.15)
    WACC 8.2% · starting FCFF 3.7 m USD · terminal value share of EV 77%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): 22.1%
  • Peers: EV/EBITDAunavailable · the base of the ratio is not positive
  • Peers: P/Eunavailable · the base of the ratio is not positive
  • Dividend discount (DDM)3.29 – 4.42 (Mid 3.77)
Multiple comparisons use the SIC vertical: Miscellaneous Chemical Products (SIC 2890)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Insufficient data

Minimum-evidence gate: score weight coverage: 43.8% of at least 60%

FactorValueScoreWeight used
ROIC · Quality-19.0%17 (vs peers)24%
Net margin · Quality-38.5%14 (vs peers)14%
FCF conversion · Qualityunavailableunavailable—
Revenue CAGR 3Y · Growth5.3%44 (on a fixed band)19%
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheet-17.5x0 (on a fixed band)14%
Current ratio · Balance sheet1.2x33 (on a fixed band)10%
P/E (TTM) · Valuationunavailableunavailable—
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuation1.7%21 (on a fixed band)19%
Shareholder yield (distributions) · Returnsunavailableunavailable—
Payout ratio (FCF) · Returnsunavailableunavailable—

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet13/100 · 2/3 factors with a value
  • Growth· partial44/100 · 1/2 factors with a value
  • Quality16/100 · 2/3 factors with a value
  • Returns· partialunavailable · 0/2 factors with a value
  • Valuation· partial21/100 · 1/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

ARQ, INC. (ARQ). Latest full fiscal year: 2025; data up to 2026-09-30.

Figures computed from the financial statements: revenue 120.3 m USD in 2025; YoY growth 10.4%; net margin -38.5%; ROE -25.0%.

The estimated value range is 2.06–3.05 USD per share (median of 2 methods, agreement: low); assumptions are illustrative. Against the central value of 2.46 USD, the price of 1.85 USD leaves a potential of 32.9% (value / price − 1) and a margin of safety of 24.7% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (score weight coverage: 43.8% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • The price is below the estimated value range

What contradicts it

  • ROIC: -19.0%
  • Net margin: -38.5%
  • Interest coverage: -17.5x
  • FCF yield: 1.7%
  • The valuation methods diverge

Not assessed (insufficient data or a ratio without meaning): FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, Shareholder yield (distributions), Payout ratio (FCF).

Versus the vertical median

Miscellaneous Chemical Products (SIC 2890) · same industry (4-digit SIC) · compared with 7 companies

Multiples and returns vs the median

P/E
—
vertical median 31.7x
EV/EBITDA
—
vertical median 10.3x
P/S
0.6x
vertical median 2.3x
below median (−72.2%)
P/B
0.5x
vertical median 2.4x
below median (−80.3%)
ROE
-25.0%
vertical median 7.4%
below median (−436.8%)
Net margin
-38.5%
vertical median 5.2%
below median (−835.7%)
EBIT margin
-38.3%
vertical median 11.7%
below median (−426.8%)
Revenue YoY
10.4%
vertical median 3.8%
above median (+172.0%)
Net debt/EBITDA
—
vertical median 0.6x
Dividend yield
0.0%
vertical median 1.5%
below median (−100.0%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
ESIElement Solutions Inc8.1 bn39.67.4%5.9%+3.8%+29% / +60%
CBTCabot Corp3.9 bn21.112.1%5.2%−7.0%+20% / −1%
WDFCWd-40 Company3.1 bn38.330.4%12.0%+11.0%+19% / −4%
FTKFlotek Industries Inc895.4 m25.037.8%13.0%+26.9%+73% / +685%
OECOrion S.A.331.8 m—-8.1%-1.8%−3.8%+16% / −75%
ASPIASP Isotopes Inc.292.8 m—-80.9%-380.3%+475.5%−69% / −1%
ARQArq, Inc.81.8 m—-25.0%-38.5%+10.4%−71% / +1%
FSIFlexible Solutions International, Inc80.1 m—-8.2%-8.8%+0.7%−8% / +313%

1- and 3-year price returns: for ARQ from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
3 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
5 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
What moves the 3-year price the most

    AI analysis

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    Possibly outdated: the newest document it read is from 10 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results), 10-Q (04 Nov 2026).

    In brief

    Arq is a producer of activated carbon used to purify air, water and soil, with powdered activated carbon (PAC) generating most of its revenue. In 2026 the company reaffirmed its financial guidance but paused granular activated carbon (GAC) production because of design flaws, so the progress of this line is central to its outlook. Quarterly and annual revenue are growing moderately, with figures cited in the dedicated lines.

    SWOT

    Strengths

    • The company has an integrated supply chain, with its own lignite mining, and a solid position in PAC, the line generating most revenue 13.
    • Several consecutive quarters of positive Adjusted EBITDA show improving profitability of the core business 3.
    • The company has experience with purification technologies used in regulated sectors, which supports its position with customers 1.

    Weaknesses

    • The GAC line does not run at nameplate capacity because of design flaws, and production has been paused 12.
    • Debt and liquidity pressure are significant, and refinancing may be difficult 12.
    • Dependence on a few large customers and on output from a single main plant creates high operational risk 1.

    Opportunities

    • The PAC for PFAS solution could expand volumes and margins without large investment in new equipment 3.
    • Monetizing the Corbin facility and related technologies could bring additional funding 3.
    • Electricity demand and drinking water rules could support volume growth over the medium term 13.

    Threats

    • A drop in coal demand for power, if natural gas becomes cheaper, could directly hurt PAC sales 1.
    • Litigation with the firm that designed the GAC facility may bring extra costs and uncertainty 12.
    • Larger competitors with stronger financial resources could cut prices or win customers 1.

    Risks

    • GAC facility defectshigh

      If design issues cannot be resolved or costs rise above estimates, the growth plan could be delayed or abandoned 12.

    • Liquidity and financinghigh

      If additional financing cannot be obtained on acceptable terms, the company could be forced to postpone necessary investments 13.

    • Debt and covenantsmedium

      Breach of covenants in existing credit agreements could lead to acceleration of outstanding debt 1.

    • Customer concentrationmedium

      Loss of one of the main customers would have a significant effect on revenue 1.

    • Leadership changeslow

      Recent departures from the executive team and related costs could disrupt execution of the strategy 3.

    Investment thesis

    What would need to be true (bull case)

    • If the PAC line keeps improving profitability and the PAC for PFAS solution proves useful, the company could grow volumes and margins without large investment.
    • PFAS regulation and electricity demand could support medium-term growth in demand for Arq's products.
    • Monetizing the Corbin facility could provide funds that ease pressure on liquidity.

    What would break the thesis

    • If the GAC facility problems are not resolved, the company could be left without an important growth line.
    • If natural gas stays cheap, coal demand in power generation could fall, hurting PAC sales.
    • If financing becomes more expensive or harder to obtain, the company could have to cut investment.

    What to watch

    • Progress of the optimization review and GAC restart costs2026
    • Customer testing of PAC for PFAS and related volumes2027
    • Delivery against fiscal 2026 revenue and Adjusted EBITDA guidanceQ4 2026
    • Level of debt and liquidity after any new financingnext 10-K

    Products, market & competition

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    Possibly outdated: the newest document it read is from 10 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results), 10-Q (04 Nov 2026).

    The business

    Arq, Inc. is an environmental technology company that mainly sells consumable activated-carbon solutions for treating air, water and soil, including for the reduction of mercury and PFAS 1. Its main products are powdered activated carbon (PAC) and granular activated carbon (GAC), and it owns the Five Forks Mine in Louisiana, which supplies the primary raw material for most products 1. The company operates the Red River Plant in Coushatta, Louisiana, and the Corbin Facility in Kentucky, the latter idled as a cost-saving measure 1.

    Customers are mainly in coal-fired power generation and municipal water treatment, and contracts generally run one to five years 1. Revenue is seasonal, usually higher in the first and third fiscal quarters, depending on electricity demand and water treatment needs 1. Three top customers account for a substantial share of sales, so the loss of any one would materially affect results 1.

    In 2026 the company continued to publish quarterly results and annual guidance, while focusing on a review of its production optimization, including possible changes to the GAC facility 23. Guidance for fiscal 2026 targets revenue of 120 to 125 million dollars and Adjusted EBITDA of 17 to 20 million dollars 3.

    Segments

    Powdered activated carbon (PAC)

    PAC is the company's core business line, with revenue of 120.3 million dollars in fiscal 2025 and 29.9 million dollars in the second quarter of 2026 13. The company describes it as the basis of its profitability, supported by better pricing and higher volumes 3.

    Market context

    Demand for Arq's products depends on air and water quality rules, especially in the United States, and on electricity demand from coal-fired generation 1. The company cites PFAS removal requirements for drinking water and growing power demand from data centers and electric vehicles as growth drivers 21.

    The market has remained favorable, with excess demand relative to supply in the GAC segment, but environmental policy and natural gas prices add uncertainty to coal demand 12. The April 2027 PFAS monitoring deadline is an important reference point for the market 3.

    Trends

    • PFAS regulationtailwind

      New drinking water rules and PFAS reporting deadlines could increase demand for activated carbon if utilities choose PAC or GAC solutions 13.

    • Natural gas pricestailwind

      Higher natural gas prices can make coal more competitive in power generation, which would support demand for Arq's products 12.

    • Declining coal-fired generationheadwind

      Coal-fired power generation in the United States continues to decline over the long term, and recent regulatory decisions could change this trend with uncertain effects on demand 1.

    • Seasonality and weathermixed

      Extreme temperatures and power plant maintenance outages can change volumes sold, which makes quarterly revenue volatile 12.

    Competitive position

    The primary competitors in the activated carbon consumables industry are Norit Americas, owned by One Equity Partners, and Calgon Carbon, owned by Kuraray Co., Ltd. 1. Beyond these two, the company faces smaller producers and distributors 1.

    Arq states that its advantage is a vertically integrated domestic supply chain, based on its own lignite mine, which gives it access to feedstock for PAC 1. The company believes this integration lets it compete better than certain other market participants 1.

    • Norit Americas

      Activated carbon producer owned by One Equity Partners and a primary competitor in carbon consumables 1.

    • Calgon Carbon

      Activated carbon producer owned by Kuraray Co., Ltd., a direct competitor in water and air purification applications 1.

    • Kuraray Co., Ltd.

      Parent of Calgon Carbon, competing indirectly through this subsidiary 1.

    • Other smaller producers and distributors

      Smaller suppliers and distributors add competitive pressure, particularly in niche segments 1.

    News & filings

    In the press

    No news in our archive over the last 180 days.

    SEC filings

    • Current report04 Nov 2026
      Results of operations · Financial statements and exhibits
    • Quarterly report04 Nov 2026
    • Current report28 Aug 2026
      Departure or appointment of officers · Other events · Financial statements and exhibits
    • Current report10 Aug 2026
      Results of operations · Financial statements and exhibits
    • Quarterly report10 Aug 2026
    • Current report23 Jul 2026
      Departure or appointment of officers · Financial statements and exhibits
    • Current report02 Jul 2026
      Departure or appointment of officers · Financial statements and exhibits
    • Current report18 Jun 2026
      Departure or appointment of officers
    • Current report11 Jun 2026
      Departure or appointment of officers · Shareholder vote · Financial statements and exhibits
    • Current report27 May 2026
      Departure or appointment of officers · Other events · Financial statements and exhibits

    Sources

    1. [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Arq, Inc. · 10 Mar 2026
    2. [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Arq, Inc. · 10 Aug 2026
    3. [3] Form 8-K, results release (exhibit 99.1) · SEC / Arq, Inc. · 10 Aug 2026

    Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.